Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.
about
Role of CSF-1 in progression of epithelial ovarian cancerInhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma.Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice.Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells.Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function.u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer.Effect of prostaglandin E2 on urokinase-type plasminogen activator production by human lung fibroblasts.A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
P2860
Q33694369-E5AB0F3D-30B6-4884-A759-12638ADA8D8DQ34774748-B82A66D1-86C5-49AA-BB94-84E4DE734B0FQ36180735-C207D2CB-1E35-48F0-9E1B-42A7458DC753Q36620396-DE987906-8E44-4DB0-BF4E-3900652352BFQ37739569-75983A2D-860F-482B-96AA-FB8BCB5B1513Q38324229-212F28B2-90C0-4FDA-90A3-CE5E7407103FQ40470278-A7C24E45-E2BE-4ED9-83E7-38472F7029A2Q40740643-8DC0BB4F-FB23-4F80-BBFA-C75AF195F937Q40784517-F474F9B8-E4A0-4628-8938-837344690F18Q40978991-66A5FB34-3BC6-4666-9F53-8DBE7D0E9BA7Q40994004-6D19A677-FB6D-4E03-91B6-40FE4802DCB2Q41820104-71B087A3-0A75-4987-BCDD-AB9ECF92F139Q46298888-342078DC-F73D-4655-8CF9-BB60D259BB50Q54602222-7A932880-66FA-484F-BDF5-5758B7EE0BE2Q54648087-C00D839F-973B-49B7-A3BC-CB39654DDD2F
P2860
Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.
@ast
Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.
@en
type
label
Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.
@ast
Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.
@en
prefLabel
Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.
@ast
Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.
@en
P2093
P356
P1476
Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice.
@en
P2093
P2888
P304
P356
10.1007/BF00133485
P577
1995-07-01T00:00:00Z